Cancer Family
Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000023Explore in graph →
HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000023Explore in graph →
Clinical trials
18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05339204 | The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission | unknown | N/A | 75 | National Research Center for Hematology, RussiaNETWORK | 1 | Apr 21, 2022 | clinicaltrials |
| NCT05326984 | Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia | unknown | N/A | 20 | Hospital General de MexicoOTHER_GOV | 1 | Apr 14, 2022 |
| NCT05001386 | In Vitro Drug Sensitivity Testing of Fresh Human Samples(ESAAC) | unknown | N/A | 800 | Hospices Civils de LyonOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT05269914 | Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL | unknown | N/A | 10 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Mar 8, 2022 | clinicaltrials |
| NCT05262465 | Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML | unknown | N/A | 300 | guomeiOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04950777 | Feasibility and Efficacy of Physical Literacy Screening Integration Into Pediatric Clinical Settings(PLAY II) | unknown | N/A | 200 | Boston Children's HospitalOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT05206071 | Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma | unknown | N/A | 100 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Jan 25, 2022 | clinicaltrials |
| NCT03574454 | Machine Learning in Myeloma Response(MALIMAR) | unknown | N/A | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05184595 | Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib(ADHOMY2) | unknown | N/A | 52 | Central Hospital, Nancy, FranceOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT04640909 | Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients | unknown | N/A | 23 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT05176275 | PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells | unknown | N/A | 10 | The First Affiliated Hospital of Soochow UniversityOTHER | 0 | Jan 4, 2022 | clinicaltrials |
| NCT05156554 | PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation | unknown | N/A | 80 | Sun Yat-sen UniversityOTHER | 0 | Dec 14, 2021 | clinicaltrials |
| NCT05017883 | TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Nov 4, 2021 | clinicaltrials |
| NCT04593745 | Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids(ALL) | unknown | N/A | 100 | Rabin Medical CenterOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT05088330 | A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM | unknown | N/A | 76 | The First Affiliated Hospital of Soochow UniversityOTHER | 0 | Oct 21, 2021 | clinicaltrials |
| NCT05080829 | Myeloid Mutations Register in R/R CML | unknown | N/A | 29 | Grupo Cooperativo de Hemopatías MalignasOTHER | 1 | Oct 18, 2021 | clinicaltrials |
| NCT05075655 | Endobronchial Diagnosis of Lymphoma(EnDol) | unknown | N/A | 33 | University Hospital, CaenOTHER | 1 | Oct 13, 2021 | clinicaltrials |
| NCT04320420 | Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)(APA²) | unknown | N/A | 57 | WepromOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT05024357 | A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL | unknown | N/A | 80 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05026229 | A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | unknown | N/A | 60 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05059847 | Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults | unknown | N/A | 114 | Hospital General de MexicoOTHER_GOV | 1 | Sep 28, 2021 | clinicaltrials |
| NCT04862806 | Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL | unknown | N/A | 1,000 | Bnai Zion Medical CenterOTHER_GOV | 1 | Sep 17, 2021 | clinicaltrials |
| NCT03582254 | Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years(LOCALYSE) | unknown | N/A | 62 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05000801 | Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia | unknown | N/A | 20 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Aug 20, 2021 | clinicaltrials |
| NCT04960761 | The Effectiveness of the Training Given With Audio and Picture Book Before the Surgery | unknown | N/A | 70 | Saglik Bilimleri UniversitesiOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT04370457 | MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies | unknown | N/A | 300 | Centre for Research and Technology HellasOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04920500 | Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients | unknown | N/A | 16 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.INDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04914143 | the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy | unknown | N/A | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT02530619 | Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia | unknown | N/A | 26 | Northwestern UniversityOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT03083327 | Prophylactic Early PN in HPT/BMT | unknown | N/A | 408 | University of SydneyOTHER | 2 | Apr 28, 2021 | clinicaltrials |
| NCT02748850 | Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem(DIMATE) | unknown | N/A | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04822974 | TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS(TTV-CART) | unknown | N/A | 20 | Institut Paoli-CalmettesOTHER | 0 | Mar 30, 2021 | clinicaltrials |
| NCT04319601 | Rituximab Combined With Chidamide and Lenalidomide for r/r AITL(AITL) | unknown | N/A | 26 | Zhejiang Cancer HospitalOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT01296178 | PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years | unknown | N/A | 200 | PETHEMA FoundationOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04792593 | Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | unknown | N/A | 15 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04692948 | TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04785833 | CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia | unknown | N/A | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04758442 | Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology(Hemato-Vanco) | unknown | N/A | 40 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04723342 | Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot | unknown | N/A | 180 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03955848 | INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS(NKAML) | unknown | N/A | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT03889483 | Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion | unknown | N/A | 105 | Dr. Michael EsserOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT04665063 | A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 29, 2020 | clinicaltrials |
| NCT04336501 | Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation | unknown | N/A | 20 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04666168 | A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma | unknown | N/A | 200 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 14, 2020 | clinicaltrials |
| NCT04665076 | Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors | unknown | N/A | 60 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 11, 2020 | clinicaltrials |
| NCT04100070 | Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study(DEEP) | unknown | N/A | 320 | ISIS Diabete ServiceOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04323605 | Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant(AMA-ALLO) | unknown | N/A | 50 | University Hospital, ToulouseOTHER | 1 | Dec 3, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Apr 21, 2022source: clinicaltrials